CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 504 enrolled
Drug / intervention
Epoetin alfa 450 IU/kg once a week +3 moredrug
Likely dose
Epoetin alfa 450 IU/kg once a weekfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01394991
NCT01394991Phase 4Completed
CompareCT.gov

A Randomized, Open-Label, Multicenter Study Evaluating Thrombovascular Events in Subjects With Cancer Receiving Chemotherapy and Administered Epoetin Alfa Once or Three Times a Week for the Treatment of Anemia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·interventional·Posted Jul 15, 2011·Updated Apr 5, 2012

In Brief

A Phase 4 clinical trial evaluating Epoetin alfa 450 IU/kg once a week, Epoetin alfa 150 IU/kg 3 times a week, and 2 other interventions for Anemia and Neoplasms. Completed, enrolled 504 participants.

Detailed Summary

The purpose of the study is to evaluate the safety of epoetin alfa in patients with cancer who have chemotherapy-related anemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Neoplasms
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 15, 2011
Enrollment StartJan 1, 2006
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 15.0 years ago

Interventions

Epoetin alfa 450 IU/kg once a weekdrug

450 IU/kg once a week by subcutaneous injection preferably in the abdomen for up to 4 weeks after the last dose of chemotherapy for a maximum of 26 weeks.

Epoetin alfa 150 IU/kg 3 times a weekdrug

150 IU/kg 3 times a week by subcutaneous injection preferably in the abdomen for up to 4 weeks after the last dose of chemotherapy for a maximum of 26 weeks.

Epoetin alfa 450 IU/kg once a week (QW)drug

450 IU/kg once a week (QW) by subcutaneous injection preferably in the abdomen for up to 4 weeks after the last dose of chemotherapy for a maximum of 26 weeks

Epoetin alfa 150 IU/kg 3 times a week (TIW)drug

150 IU/kg 3 times a week (TIW) by subcutaneous injection preferably in the abdomen for up to 4 weeks after the last dose of chemotherapy for a maximum of 26 weeks.